BioSpace News Archive

New in vivo studies support potential use of ibrexafungerp in skin and invasive infections caused by multidrug-resistant pathogen, Candida auris

Preparations Continue for Submission of BLA in the U.S. and MAA in Europe

Thirty of IDEA Frontier Brownsville’s most talented sophomores are bound in for University of California, LA in July to participate in the annual and transformative LEAP Week.

AI-enabled Health Insights Platform Named Top in Innovation in Healthcare Analytics

Rafael Pharma announced that its lead compound, CPI-613®, will be explored in a new combination for the treatment of T-cell lymphoma as a part of Stand Up To Cancer’s T-Cell Lymphoma Dream Team Research Grant.

The acquisition represents a strategic expansion to optimize medication access options and to support underserved regional markets, as well as Enclara’s expansion into the home care pharmacy market.

Peloton announced that it has confidentially submitted a draft registration statement on Form S-1 with the Securities and Exchange Commission relating to the proposed initial public offering of its common stock.

Medacta International announced its MySpine Midline Cortical platform has been recognized as this year’s “Best Healthcare Navigation / Robotics Solution” by MedTech Breakthrough.

The Mesothelioma Compensation Center prides themselves top-rated group in the nation when it comes to the best possible financial compensation results for a nuclear power worker or US Navy Veteran who worked on nuclear reactors on a submarine, aircraft carrier or one of eight nuclear powered US Navy Cruisers.

Devonian Health Group Inc. announced that the Corporation has filed a patent application for the use of thylakoids as delivery system for cannabinoids and other liposoluble molecules for pharmaceutical and cosmetic applications.